| Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study M Maurer, K Houghton, C Costa, F Dabove, LF Ensina, A Giménez-Arnau, ... World Allergy Organization Journal 11, 32, 2018 | 55 | 2018 |
| Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD DE Stull, I Wiklund, R Gale, G Capkun-Niggli, K Houghton, P Jones Contemporary clinical trials 32 (6), 818-828, 2011 | 35 | 2011 |
| Assessing changes in chronic spontaneous/idiopathic urticaria: comparisons of patient-reported outcomes using latent growth modeling DE Stull, D McBride, K Houghton, AY Finlay, A Gnanasakthy, MM Balp Advances in Therapy 33, 214-224, 2016 | 20 | 2016 |
| Correlation between change in psoriasis area and severity index and dermatology life quality index in patients with psoriasis: pooled analysis from four phase 3 clinical trials … K Houghton, D Patil, B Gomez, SR Feldman Dermatology and Therapy 11 (4), 1373-1384, 2021 | 19 | 2021 |
| Identifying differential responders and their characteristics in clinical trials: innovative methods for analyzing longitudinal data DE Stull, K Houghton Value in health 16 (1), 164-176, 2013 | 15 | 2013 |
| Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling … DE Stull, CEM Griffiths, I Gilloteau, Y Zhao, A Guana, AY Finlay, B Sherif, ... British Journal of Dermatology 178 (6), 1297-1307, 2018 | 10 | 2018 |
| PRS51 the development of the early morning symptoms of COPD instrument (EMSCI) A Palsgrove, K Houghton, A Hareendran, M Schaefer, J Setyawan, ... Value in Health 14 (7), A496-A497, 2011 | 10 | 2011 |
| The dollar or disease burden: caps on healthcare spending may save money, but at what “cost” to patients? M Ciarametaro, K Houghton, D Wamble, R Dubois Value in Health 24 (3), 388-396, 2021 | 9 | 2021 |
| What’s been the bang for the buck? Cost-effectiveness of health care spending across selected conditions in the US D Wamble, M Ciarametaro, K Houghton, M Ajmera, RW Dubois Health Affairs 38 (1), 68-75, 2019 | 9 | 2019 |
| Use of antifungals and outcomes among inpatients at risk of invasive Aspergillosis or Mucormycosis in the USA: a retrospective cohort study K Stull, E Esterberg, M Ajmera, S Candrilli, TM Kitt, JR Spalding, VP Patel Infectious Diseases and Therapy 8, 641-655, 2019 | 8 | 2019 |
| Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone: ICARIA-MM study K Houghton, MA Dimopoulos, P Lin, S Guillonneau, D Bury, M Attal, ... Blood 134, 1850, 2019 | 8 | 2019 |
| Staging disease severity using the Alzheimer’s Disease Composite Score (ADCOMS): a retrospective data analysis AA Tahami Monfared, K Houghton, Q Zhang, J Mauskopf, ... Neurology and therapy 11 (1), 413-434, 2022 | 7 | 2022 |
| Pmc8 using atlas. ti as a tool to extract and synthesize data obtained in literature reviewing MR Stafford, K Houghton, D Stull Value in Health 7 (12), A388, 2009 | 4 | 2009 |
| The effects of disease and treatment-associated cancer symptoms on health-related quality-of-life: the mediating effect of fatigue in non-small cell lung cancer and metastatic … DE Stull, K Houghton, C Ainsworth, G Price, ME Boye Poster presented at the 2017 ISPOR 22nd annual international meeting 22, 2017 | 3 | 2017 |
| Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: data analysis from a phase II study of abemaciclib monotherapy, a CDK4 and … M Boye, K Houghton, DE Stull, C Ainsworth, GL Price J Clin Oncol 35, 1060, 2017 | 3 | 2017 |
| Development of a frequent heartburn index DE Stull, P van Hanswijck de Jonge, K Houghton, C Kocun, DW Sandor Quality of Life Research 20, 1023-1034, 2011 | 3 | 2011 |
| “Causal cascade” among outcomes in non-small cell lung cancer: assessing the direct and indirect effects of symptoms on health-related quality of life (HRQL) outcomes DE Stull, K Houghton, C Ainsworth, J Brown, L Bowman, ME Boye Value in Health 19 (7), A748, 2016 | 2 | 2016 |
| MO556 TREATMENT OF ANAEMIA WITH ERYTHROPOIESIS STIMULATION AGENTS (ESAS) AND CONCOMITANT THERAPIES AMONG PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD … D Fliser, J Portoles, K Houghton, C Ainsworth, M Blogg, M Mata Lorenzo Nephrology Dialysis Transplantation 36 (Supplement_1), gfab085. 0019, 2021 | 1 | 2021 |
| A (latent) class of their own: response patterns in trading off quantity and quality of life in time trade-off exercises FE van Nooten, K Houghton, J van Exel, M van Agthoven, WBF Brouwer, ... Value in Health 20 (10), 1403-1410, 2017 | 1 | 2017 |
| Secukinumab provides greater improvement in quality of life, work productivity, and daily activity than ustekinumab in patients with moderate-to-severe psoriasis: a structural … L Puig, C Griffiths, I Gilloteau, Y Zhao, A Guana, A Finlay, K Houghton, ... JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 76 (6), AB231-AB231, 2017 | 1 | 2017 |
